pharmacists at work.comtoppowered by eircom
collagetop
  spacersite maphelpcontact uscommunication toolsspacer  
     
 
search this site for
  See a full list of Resources go search
business tools
  See a full list of Business Tools go search
 

Doctors in France have been advised not to prescribe Zyban, the anti-smoking drug after an independent study found that the risks of taking it outweigh the benefits.


Doctors in France have been advised not to prescribe Zyban, the anti-smoking drug after an independent study found that the risks of taking it outweigh the benefits. The research found that convulsions, hypersensitivity reactions and insomnia are linked to Zyban use.

The drug has also been associated with a number of deaths. The British Government?s chief advisor on the safety of medicines, Professor Alisdair Breckenridge, said that many cases of adverse reactions have gone unnoticed and that the number of deaths and side effects could be ten times higher than the official figure. Zyban?s manufacturer GlaxoSmithKline said there is no evidence that Zyban had caused any deaths.



log ov
Get Password?
Forgotten Password?
 
  bottom